Investment Q&A

Q: Looking BCI over as another way to play the aging population theme plus people are sitting around staring at screens most of the time, especially in the last 30 years (me too) and ruining their eyes. Your last rating on this Company was Nov 2017 @ B+. Do you still consider it worthy of a B+? If so, in the context of a year later. with very little movement, no dividend increases...why?

Thank You once again

Q: I have unfortunately bought at the high of 2015 and am even money on this one after 3 years. They appear to be doing all the right things but market's reaction isn't there.

Do you feel there will be a market catalyst on this one or would the money be better served elsewhere?

Q: Out of the stocks you cover can i get your top 7 recommendations for good long term dividend/growth stocks for a non registered account that have a good DRIP option.
TY!

Q: I like the idea of New Look Vision rolling up prescription eye glass companies. I just spent a lot for a little bit of plastic in front of my eyes. I'm not sure why BCI does not perform better. Are there a lot of intangibles in their balance sheet. My real question is whether hearing aids are part of their business. If not is there a similar company that specializes in hear aid companies?

Q: I currently own TOY (my only holding for Cyclical Consumer). I did have MG but sold it. I am wondering for a RRSP with a long time frame which 2-3 stocks of the list BCI, DOL, DOO. GSY, CCL.B. AW.UN which be best as I am trying to increase my holdings in this sector.
Thanks

Q: Can you please give us your thoughts on their latest quarter. Bouncing around a bit after what I thought looked like more of the same steady growth for them.

Q: For the past while, I have been watching BCI. I have done well with consolidators, I liked their last earnings / growth yet their presentation (my opinion) was not well delivered. Unfortunately, it has not attracted much volume. This morning they have traded 148 shares and are up 3.61%. Do they need a professional or more effective investor relations team?
Thank you

Q: I'm thinking of following your lead and selling Stella Jones in my TFSA. Also, I have a small amount of cash to deploy. I hold the above stocks in less than full positions. Which would you add to at this point? I could also include COV although it's near a full position after it's nice rise. Also, what are the implications of holding an American growth stock in a TFSA. What would be your top 3 suggestions if you were going to add an American stock. Charge as many credits as necessary! Thanks.

Q: I was surprised by the fact that New Look Vision only traded 1100 shares, as it looks to me that they had a good beat on earnings. Would you comment, please. How is BCI coming along, in your opinion?

Q: In your response this morning to Mike regarding BCI you stated: " Liquidity is an issue however so we would keep that in mind regarding a position size if adding to the name." I would appreciate it if you would explain why liquidity is an issue if I intend to take a position. Thank you.

Q: This has been under a bit of pressure over the past couple weeks. Is the 10% pullback a buying opportunity, or a red flag? Are you aware of any news? DO you still see it as an attractive long term hold?

Thanks for your help!

Q: Because of the lack of liquidity on BCI I placed a limit order at $32 for the quantity I am looking for. I realize that once I'm in it will not be easy to exit.

Your last comment on BCI was a month ago and wondering how you felt about the stock at $32 for the next 2 or 3 years.

Asking this mostly because of the illiquidity and thought $32 might make it a good buy.

Please advise.


Sheldon

Q: What is your reading of the quarterly and annual results? Has the investment thesis changed in any way?

Q: Hi 5i,

Just joined your group and so far I am liking the website and the sections. I like to invest in small to mid cap companies (currently have bbi and pmn in my portfolio). Looking to add 2-3 more over the next few weeks. Any suggestions that I can have so I look into their company? I do like PTE a bit since it dropped so much.

Q: I have a small amount of cash in my TFSA as a result of dividend income. I have less than a full position in the above companies either as a result of smaller purchases or because they have dropped since purchase. (HWO) Which of the above would you add to? Thank you, Rod

Q: I started an RESP for my granddaughter in May 2017 with equal weights of PBH, MX, BNS, SIS, KXS and ZCL. The total return of the RESP is 10% YTD. When ZCL had a poor earnings report in November 2017, I sold those shares and purchased ENB. Going forward, would you suggest any changes to the current holdings, and what would you purchase with new contribution money? My best wishes of the holiday season to the wonderful 5i staff, as well as all 5i members!

Q: Great call on PUR ,but what to replace it with?
Can you give a heads up on some ideas for replacement?
Been looking at HEO,but you do not seem to be favorable on this stock.
Please give me 3 names,it does not have to be sector related specifically.

Q: What would you suggest to replace PUR, in comparable sector and market cap and any other best option at this time.

Q: Hello Peter and Team,

I do like BCI quite a bit as people need glasses. It's one of those boring areas of the market that is a necessity. A couple questions though:
Would BCI be considered a staple or a discretionary stock? I feel like it should be a staple as vision is not something I would forgo.
As well, in your report there isn't any mention of how laser surgery is affecting a market. I do know quite a few people that have undergone laser surgery and who widely recommend it to others. How much is laser surgery affecting the marketplace? And how is cheap alternatives online affecting the marketplace?

Thank you for your great service as always!

Wes

Q: Hi team,

I am heavy in tech as usual and have to scale back every once in a while. I now have some cash to deploy in other sectors. I offset my tech with industrials, financials, consumer and utilities. I avoid resources as I find it just drains my capital. I am growth and an “active” investor.

I am looking at adding a consumer stock, either BCI or ZZZ. I read your recent report on BCI and am intrigued by the trend of aging demographics and the increasing need for glasses and contact lenses. You give it a relatively strong B+ rating and it is in your Growth portfolio. I have been watching it the past week or so. It is a very thin trader. No trades at all today and bid/ask about $1.00 apart, a wide spread for a $35 stock. Would have been wider except for my bid which did not get filled.

I used to own ZZZ and got lucky in selling before the last earnings release when it missed estimates. I have been watching that lately as well. It seems to be moving up steadily from $32 and now hovers above $33, still well off its 52 week high. On Monday, the TSX approved a NCIB for ZZZ that is normally supportive of the share price.

So, should I buy some eyeware or sleepware or a bit of both to get a good night’s sleep?

Thanks again,
dave